ImmersiveTouch, a virtual reality-enabled personalized surgery, is expanding the availability of its platform into the neurosurgery market and has engaged a large medical device manufacturer on a co-marketing campaign.
The Chicago-based company announced the expansion simultaneous to its collaboration with Indiana medical device giant Zimmer Biomet that gives the company’s surgeons access to ImmersiveTouch’s VR surgical tools that will streamline the viewing, planning and simulation of interventional procedures.
ImmersiveTouch offers a suite of products focused on virtual reality software that allows surgeons to simulate procedures. The technology renders data from a CT scan or MRI into an immersive 3D, interactive VR reconstruction of the patient’s anatomy, allowing doctors to rehearse patient-specific procedures.
The system converts medical images into a digital copy of the patient to provide an unobstructed view of the case in virtual reality.
The virtual reality surgery technology’s expansion to neurosurgery aligns with Zimmer Biomet’s craniomaxillofacial surgical solutions that includes implants, instruments, e-tools, and patient-matched services.
In the announcement, University of Chicago Plastic Surgeon Russell Reid said the technology gives him the ability to see in the operating room what was not seen prior to surgery.
“The power of ImmersiveView is akin to having a GPS system on an unmapped road,” he said.
On its website, ImmersiveTouch says it serves five specialites, including:
- Craniomaxillofacial surgery
- Ear, nose and throat surgery
- Cardiothoracic surgery
- Spine surgery
ImmersiveTouch also offers training and educational programs tailored for medical schools, simulation centers and medical device manufacturers. The company also offers the ability to create custom projects for training, entertainment, gamification of surgical instructions for use and simulations.
Virtual reality is becoming a commodity in the healthcare industry, with the segment expected to grow to nearly $4 billion by 2020 and as much as $5.1 billion by 2025.